The incidence of malignancy in patients with thyroid nodules: A prospective population study

Habeeb Ali Yaseen; Adel Khdair Abbas

doi:10.53730/ijhs.v6nS3.7884

Authors

Habeeb Ali Yaseen Department of general surgery, Al – Kadhimain Medical City, Baghdad, Iraq
Adel Khdair Abbas Department of general surgery, Al – Kadhimain Medical City, Baghdad, Iraq

Keywords:

thyroid nodules, malignancy, non – neoplastic, follicular neoplasm

Abstract

Background: Thyroid nodules are extremely common with a prevalence about 20 – 76% of adult population. Thyroid cancer is present in about 5% of nodules, even though rates as high as 15% have been reported. To determine whether the nodule is benign or malignant, fine needle aspiration biopsy (FNA biopsy) is the clinical procedure of choice.

Objective: to evaluate thyroid nodules in order to determine the incidence of malignancy in these nodules. Patient and Methods: A prospective study was conducted among 415 patients presented with thyroid nodules in the surgical outpatient clinic in Al – Kadhimain medical city from February 2020 to February 2022. Patients between 15 t0 75 years of age, both male and female patients, were included in this study. The assessment was done by thorough history, clinical examination, thyroid profile test, neck ultrasound and fine needle aspiration cytology. After fine needle aspiration, diagnostic cytology was classified according to British Thyroid Association guidelines as THY1: non diagnostic, THY2: benign (non - neoplastic), THY3: intermediate (including follicular neoplasm), THY4: suspicion of malignancy and THY5: diagnostic of malignancy.

Downloads

Download data is not yet available.

References

Hoang JK, Lee M, Johnson D, Farrell S: US features of thyroid malignancy: pearls and pitfalls. Radiographics 2007; 27: 847 – 865.

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France: International Agency for Research on Cancer; 2013.

Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, Zhang Y, Bai Y, Zhu C, Guo GL, Rothman N, Zhang Y. International patterns and trends in thyroid cancer incidence, 1973 – 2002. Cancer Causes Control. 2009; 20 (5): 525 – 531.

Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, Devesa SS: Rising thyroid cancer incidence in the United States by demographic and tumor charecteristics 1980 – 2005. Cancer Epidemiol Biomarkers Prev 2009; 8: 784 – 791.

Ghrib H, Goellner JR: Fine – needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 1993; 118: 282 – 289.

Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES, Orcutt J, Moore FD Jr, Larsen PR, Marqusee E, Alexander EK: Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab 2006; 91: 3411 – 3417.

Hegedus LN: The thyroid nodule. N Engl J Med 2004; 351: 1764 – 1771.

Amrikachi M, Ramzy I, Rubenfeld S, Wheeler TM: Accuracy of fine – needle aspiration of thyroid. Arch Pathol Lab Med 2001; 125: 484 – 488.

Pacini F, Schlumberger M, Dralle H, Elisie R, Smit JWA, Wiersinga W: European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006; 154: 787 – 803.

Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, Mclver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM: Revised American Thyroid management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167 – 1214.

Boelaert K, Haracek R, Holder L, Watkinson M, Sheppard C, Franklyn JA: Serum thyrotropin concentrations as a novel predictor of malignancy in thyroid nodules investigated by fine – needle aspiration. J Clin Endocrinol Metab 2006; 91: 4295 – 4301.

Liebeskind A, Sikora AG, Komisar A, Slavit D, Fried K: Rate of malignancy in incidentally discovered thyroid nodules evaluated with conography and fine needle aspration. J Ultrasound Med 2005; 24: 629 – 634.

Kim DL, Song KH, Kim SK: High prevalence of carcinoma in ultrasonography – guided fine needle aspiration cytology of thyroid nodules. Endocr J 2008; 55: 135 – 142.

Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nardi F, Claudio P, Rinaldi R, Toscano V, Pacella CM: Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color Doppler features. J Clin Endocrinol Metab 2002; 87: 1941 – 1946.

Sabastian – Ochoa N, Fernandez – Garcia JC, Mancha Doblas I, Sabastian – Ochoa A, Fernandez – Garcia D, Ortega Jimenez MV, Gallego Dominguez E, Tinahones Madueno F: Clinical experience in a high – resolution thyroid nodule clinic. Endocriol Nutr 2011; 58: 409 – 415.

Lakhani R, Rourke T, Jefferis A, Perry L, Ghiacy S, Wood S: Thy3 cytology: what to do next? Ann R Coll Surg Engl 2011; 93: 225 – 228.

Ustun B, Chhieng D, Prasad ML, Holt E, Hammers L, Carling T, Udelsman R, Adeniran AJ: Follicular variant of papillary thyroid carcinoma: accuracy of FNA diagnosis and implications for patient management. Endocr Pathol 2014; 25: 257 – 264.